Free Trial

AstraZeneca (AZN) News Today

£123.22
+78.00 (+0.64%)
(As of 07:52 AM ET)
Analysts Set AstraZeneca PLC (LON:AZN) Target Price at £105.53
AstraZeneca logo with Medical background
AstraZeneca PLC (LON:AZN) Given Average Recommendation of "Moderate Buy" by Brokerages
AstraZeneca PLC (LON:AZN - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the nine analysts that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a bu
AstraZeneca's (AZN) "Buy" Rating Reaffirmed at Shore Capital
AstraZeneca logo with Medical background
AstraZeneca (LON:AZN) Stock Rating Reaffirmed by Shore Capital
Shore Capital reiterated a "buy" rating on shares of AstraZeneca in a report on Friday.
AstraZeneca logo with Medical background
AstraZeneca (LON:AZN) Shares Cross Above 200-Day Moving Average of $11,163.66
AstraZeneca (LON:AZN) Share Price Crosses Above 200 Day Moving Average of $11,163.66
AstraZeneca logo with Medical background
AstraZeneca (LON:AZN) Price Target Raised to GBX 74 at Jefferies Financial Group
Jefferies Financial Group upped their price objective on AstraZeneca from GBX 71 ($0.90) to GBX 74 ($0.94) and gave the stock a "hold" rating in a report on Tuesday.
AstraZeneca logo with Medical background
AstraZeneca PLC (LON:AZN) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of AstraZeneca PLC (LON:AZN - Get Free Report) have earned an average rating of "Moderate Buy" from the nine research firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a h
AstraZeneca logo with Medical background
AstraZeneca (LON:AZN) Given "Hold" Rating at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a £110 ($139.77) price target on shares of AstraZeneca in a report on Tuesday.
AstraZeneca logo with Medical background
AstraZeneca (LON:AZN) Share Price Crosses Above 200 Day Moving Average of $10,937.73
AstraZeneca (LON:AZN) Stock Price Passes Above Two Hundred Day Moving Average of $10,937.73
AstraZeneca (LON:AZN) Hits New 12-Month High at $12,586.00
AstraZeneca (LON:AZN) Sets New 12-Month High at $12,586.00
AstraZeneca (LON:AZN) Stock Rating Reaffirmed by Citigroup
Citigroup reissued a "buy" rating on shares of AstraZeneca in a research note on Tuesday.
AstraZeneca PLC (LON:AZN) Given Average Rating of "Moderate Buy" by Brokerages
Shares of AstraZeneca PLC (LON:AZN - Get Free Report) have been assigned an average rating of "Moderate Buy" from the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold r
JPMorgan Chase & Co. Reaffirms Overweight Rating for AstraZeneca (LON:AZN)
JPMorgan Chase & Co. restated an "overweight" rating on shares of AstraZeneca in a report on Tuesday.
AstraZeneca (LON:AZN) Stock Crosses Above Two Hundred Day Moving Average of $10,561.77
AstraZeneca (LON:AZN) Shares Cross Above 200-Day Moving Average of $10,561.77
AstraZeneca (LON:AZN) PT Raised to £130 at Berenberg Bank
Berenberg Bank raised their price target on shares of AstraZeneca from £120 ($150.75) to £130 ($163.32) and gave the company a "buy" rating in a report on Friday.
AstraZeneca Q1 Profit, Revenues Climb; Backs FY24 Outlook
AstraZeneca (LON:AZN) Upgraded at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft upgraded AstraZeneca to a "hold" rating in a research report on Monday.
AstraZeneca (LON:AZN) Rating Reiterated by Shore Capital
Shore Capital restated a "buy" rating on shares of AstraZeneca in a research note on Monday.
AstraZeneca (LON:AZN) Reaches New 1-Year Low at $105.92
AstraZeneca (LON:AZN) Reaches New 12-Month Low at $105.92
AstraZeneca (LON:AZN) Receives "Overweight" Rating from Barclays
Barclays reaffirmed an "overweight" rating and issued a £125 ($156.92) price objective on shares of AstraZeneca in a research note on Monday.
AstraZeneca (LON:AZN) Given "Overweight" Rating at JPMorgan Chase & Co.
JPMorgan Chase & Co. reiterated an "overweight" rating on shares of AstraZeneca in a research note on Thursday.
AZN Apr 2024 72.000 call
AZN May 2024 67.500 call
AstraZeneca's (AZN) "Sell" Rating Reiterated at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft reiterated a "sell" rating on shares of AstraZeneca in a report on Tuesday.
AstraZeneca PLC (LON:AZN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
AstraZeneca PLC (LON:AZN - Get Free Report) has been given an average rating of "Moderate Buy" by the ten brokerages that are presently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and seven have issued
AZN Apr 2024 60.000 put
Deutsche Bank Aktiengesellschaft Reaffirms Sell Rating for AstraZeneca (LON:AZN)
Deutsche Bank Aktiengesellschaft restated a "sell" rating and set a GBX 9,500 ($120.50) target price on shares of AstraZeneca in a report on Tuesday.
AZN Apr 2024 67.000 call
AZN Mar 2024 57.000 call
Get AstraZeneca News Delivered to You Automatically

Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.

Home To The World’s Largest High-Grade Uranium Deposits (Ad)

Nuclear is one of the safest forms of energy around. In its entire history, nuclear is responsible for fewer deaths than oil and gas pollution cause every year. And investors are eyeing uranium exploration companies as one of the surest plays on the current nuclear renaissance.

Click here to see why this could be one of the greatest periods for the nuclear industry ever

AZN Media Mentions By Week

AZN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AZN
News Sentiment

0.32

0.93

Average
Medical
News Sentiment

AZN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AZN Articles
This Week

5

2

AZN Articles
Average Week

Get AstraZeneca News Delivered to You Automatically

Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (LON:AZN) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners